Rebound Hypertension
Definition and Mechanism
- Rebound hypertension represents a sudden elevation in blood pressure that can exceed pre-treatment levels after sudden withdrawal of certain antihypertensive medications, particularly beta blockers and centrally acting alpha-2 agonists like clonidine, according to the American Heart Association 1, 2, 3
- The phenomenon is most commonly associated with centrally acting alpha-2 agonists and beta blockers, which can cause sympathetic nervous system overactivity and increased plasma norepinephrine levels 2, 4
Medications Associated with Rebound Hypertension
- Centrally acting alpha-2 agonists, such as clonidine, require tapering to avoid rebound hypertension, as recommended by the American College of Cardiology 4, 5
- Beta blockers carry a risk of rebound hypertension with abrupt discontinuation and require gradual tapering, according to the American Heart Association 4, 6
Prevention Strategies
- Gradual tapering is essential for high-risk medications, including beta blockers and clonidine, to reduce the risk of rebound hypertension, as recommended by the American College of Cardiology 2, 4, 9
- Perioperative considerations include continuing beta blockers throughout the perioperative period and considering transdermal formulations or IV alternatives for clonidine, according to the American Heart Association 2, 3, 10
Management of Rebound Hypertension
- Prompt treatment is necessary to prevent complications if rebound hypertension occurs, and intravenous antihypertensives may be required to control blood pressure, as recommended by the American College of Cardiology 8, 10
Special Considerations
- Close monitoring of blood pressure is essential when tapering high-risk medications, according to the American Heart Association 8